Thus, repression of p53 expression by STAT3 is likely to have an important role in development of tumours and targeting STAT3 represents a novel therapeutic approach for p53 reactivation in many cancers lacking p53 mutations (Niu et al., 2005). Here, TP53 is linked to neoplasm.